Tag | Content |
---|
EnhancerAtlas ID | HS139-05423 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr1:244607890-244609920 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EBF1 | MA0154.3 | chr1:244608337-244608351 | TCTCCCTTGGGAAT | - | 6.01 | LMX1B | MA0703.2 | chr1:244608037-244608048 | ATTTTAATTAA | + | 6.62 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_05523 | chr1:244607983-244611433 | Brain_Cingulate_Gyrus | SE_07255 | chr1:244607616-244616510 | Brain_Hippocampus_Middle_150 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I244444 | chr1 | 244608104 | 244609701 |
|
Enhancer Sequence | GTATCTCATC ACAGAGCTAT GAAATAAACT GGAACATCAT GATAGAAACA AAAAGCAGGA 60 CTAAAATTCT ATGTTCTCAA AGCTGAAAAG CAAAGTTTCT GATGTATGCT TTTAGTTTTT 120 ACCATCAATA CATAGCTAAT TTTCATTATT TTAATTAAGG TTAAAATAAT AAAAACCAAT 180 TTAACTCTAT TTTTTGTTCC AGAAAAGCAC TACAGGTCAA TAGCACATTA GAGTTTTGGA 240 AAACAATTTA TAAATGAGAA CAATCCAGAA CAAATGCTTC CTCATACCTT ATTTTCCTAT 300 ACAAAATTAA CTCCAGGTTA GTTATAGCTT TTGTATGCTC AGTCCCCCTC CTTTTCCCCT 360 ACTTTGCAAA TCATAGGAAT CATCCCCCCA GCCACAGCAA ACTGATCCAG GCAGGGAAAC 420 ATGTTCCAAC CTGAGCCAGT CAGCTCCTCT CCCTTGGGAA TCTGAATTTG AGTACTGAGA 480 AGGAAAGCAA TAGCAGTCTG AGATGCCTGT CACCTACGGG AAGCATCCTA AAGAAAAAGG 540 TTGCCAGTTC TAGCTGCTGA AATTCCAGGA GCAGGCTTCA TCTCAGGCCA CCATCCTGCT 600 CTTCCTTTAA ACAAATCCCC ATTTTGCTTG AGATAGTTTC TTTCCATTGC TTGCAAACAA 660 AGAACACAAA TGATTCACAA AAAAAACTTA CTACAACATA ATATACACCT TGCTGAATTT 720 ACATCTTGTA CTAGTGAAAC TGAATATTAA AATGATTGCT AGATATTAAT AACATTTTAT 780 GCTGTCAAGG ACAATACTTT AAAGCATTAC TGCAGGATAG AGGAATGATA TAATAGTATT 840 TAGTTATTCT GTAACTGTTC TCAGTTTTTC CATGCATTCC TTTTCTTCCT AATTTGATGT 900 TTAGTTTAAG GAAGTCGGAA GACAAGTGTT TTGAATTTTC TTTCCATGAC TCCTCAGAAC 960 CAGAGGCTGT CAAATCCAAT TATAGAATAA AATTTTGGAT CAGGAAATGC TAATATGTGT 1020 AAGCTTCTAG CTAAGAAGCT CCAAAGGTCC AGGGGAGGTT AAAAAAAAAA AAAGTTTGGA 1080 AAGGAATTAA ATGATATTAG TTTACAAAAG TGACTCTTGA TTCTTAACTT GGTTTCACTA 1140 CTGGGCCTTC TCCTTCCCTA AATCACTCCT TTCTTCGCTC CCCCAAGTGC ATTTCTGCTG 1200 TGGTAGAGAG ATGAAGGCAG TGAATGATCC TCAGTGTTGT AAACCTGAAA CAATGGTCTC 1260 TTTTCCAGAA TACAGGCCCA AGTGTCAAGG GCTACCAATT TCATGCACAA AGCCCAGAGG 1320 CATTTTTCAG GCTAGTTAGG CCTCTGTGTC TTATCTTTGT CCTTTTGCTT TGAATATATG 1380 AACAACCTAC TGTAATCACA GAGCTCAAAA TGAACATCAG GAAGTCAGTG GCCACTATGG 1440 ATTACAGGAG AGAGCAGCAG TGTCTCAGAT CCCATGCCCC TGAACTATTT CAGCAACCAA 1500 AAAAGGGTTG CTATTTTTTT GTCTAATCTT CAAACTTCTT AAGAGCCTAA AAATCTTTGG 1560 AGTCAATGCT TATTATCTAT GCTGCTTTCA GGGTAAAGAT TGTAAGATCT GTGTCTCCTC 1620 CTTTCCAGAT GAAACATGTT ACCATTCACC AAAACTAAAG CACTTATCAA TCCACAGCAA 1680 TAAAGCAGTT ATAAATGATG ATTGTTCTTT CATGAAAGCA TTCACATAAC TGCAATTAGC 1740 TTATGATTCC AAAGTAGAGC AGGTTAAGTT ACTACCAGCA AGTTGATCAA ATTTAACTAT 1800 GTAGCAGTAA CCAGACACAC TAGACAGCAA GAGAAAAAAA TACACAGGGT ATCTGAATTT 1860 CTTTCTAGCA AAGATATCCC AGCTCAGTTA TCCATTAAAG GTTTAAAGGT ATCCACTTTA 1920 CTTTGCATGA TTATAGTTAC CTTCTAGTTT CATACACACA TAAATGTCAC AAATGATGAA 1980 AACCTCAGAT ACCTTATATT TTAGACCTAA CATTACTATT ATGAAATAAC 2030
|